• OPEN AN ACCOUNT
Indian Indices
Nifty
22,502.00 35.90
(0.16%)
Sensex
74,005.94 88.91
( 0.12%)
Bank Nifty
48,199.50 83.85
( 0.17%)
Nifty IT
33,438.75 56.90
( 0.17%)
Global Indices
Nasdaq
16,685.97 -12.35
(-0.07%)
Dow Jones
40,003.59 134.21
(0.34%)
Hang Seng
19,636.22 82.61
(0.42%)
Nikkei 225
39,069.68 282.30
(0.73%)
Forex
USD-INR
83.47 0.01
(0.01%)
EUR-INR
90.76 0.22
(0.25%)
GBP-INR
105.79 0.36
(0.34%)
JPY-INR
0.54 0.00
(0.51%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
346.471431
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
30.52
113350.18
EPS(TTM)
Face Value()
Div & Yield %
46
2
0.61
 

cipla ltd
Cipla's unit at KurKumbh completes USFDA inspection
May 08,2024
Cipla announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at manufacturing facility of the Company located in Kurkumbh, Maharashtra, India from 29 April 2024 to 8 May 2024. On conclusion of the inspection, the Company has received 1 inspectional observation in Form 483.